Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
letter
. 2021 Jun 24;599(14):3627–3628. doi: 10.1113/JP281882

A more holistic view could contribute to our understanding of ‘silent hypoxaemia’ in Covid‐19 patients

Eric Mulder 1,, Frank Pernett 1, Erika Schagatay 1
PMCID: PMC8242895  PMID: 34047369

The article written by Simonson et al. (2021), ‘Silent hypoxaemia in COVID‐19 patients’, provides a comprehensive and interesting review on how hypoxaemia is related to dyspnoea. However, we would like to address some points that need further clarification.

Firstly, the terms ‘happy hypoxia’ and ‘silent hypoxia’ are based on the clinician's perception of an expected response related to levels of oxygen saturation (SpO2; Tobin et al. 2020), which implies that the only symptom of hypoxaemia is dyspnoea. Dyspnoea, however, is complex and difficult to define, as it can be perceived in different ways – not only by ‘air hunger’ (Tobin, 1990). As dyspnoea is a subjective experience, it is difficult to match specific levels of arterial partial pressures of oxygen (PaO2) with this symptom. Indeed, a more appropriate term could be ‘asymptomatic hypoxia’, as we need to measure many variables including tissue hypoxia to be sure that it is ‘silent’.

Humans have been dealing with hypoxia in many different ways across our evolution, both as breath‐hold divers (Schagatay, 2009) and as indigenous permanent inhabitants of moderate to high altitude regions of the Tibetan plateau, the Andes, Eastern Africa and North America (Huang, 2014; Simonson, 2015; West, 2019), proving that humans can thrive even in conditions of hypoxia. In addition, even in critical care patients, some levels of hypoxaemia could be accepted (permissive hypoxaemia) if tissue oxygenation is not affected (Martin & Grocott, 2013; Panwar et al. 2016). The individual response to hypoxia is highly variable; therefore it is difficult to define a precise threshold value of PaO2 and SpO2 (Tobin et al. 2020). Another important factor is timing, as the concept of acclimatization plays an important role in the response to hypoxia in order to cope with the restricted supply of oxygen (West, 2006). In COVID‐19 patients, dyspnoea typically occurs 8–12 days after the onset of symptoms (Li & Ma, 2020; Zhou et al. 2020). Since it has been shown that acclimatization to high altitude takes between 4 and 8 days (Rahn & Otis, 1949), it may be possible that a similar process occurs in COVID‐19 patients, having to cope with hypoxia for several days, hence reducing their oxygen consumption accordingly (West, 2006).

Secondly, we would like to clarify some statements about breath‐hold diving. In the review, the authors cite two references (Lindholm & Lundgren, 2006; Overgaard et al. 2006) to explain normal arterial partial pressures of carbon dioxide (PaCO2) at the end of a breath‐hold. Parenthetically, hyperventilation is avoided nowadays in competitive breath‐hold diving, as it is a risk factor for hypoxic syncope (Pearn et al. 2015). Regardless, Overgaard et al. (2006) found end‐tidal partial pressures of carbon dioxide (PET,CO2) at the end of breath‐holding (at different lung volumes) ranging between 45.7 and 50.2 mmHg, which is not in the normal range. A classical study on exhaled gases (Liner & Linnarsson, 1994) found a baseline PET,CO2 of 39 mmHg, which, after a surface breath‐hold, had gone up to 46 mmHg, while it was 45 mmHg after a simulated 20 m dive. Recently, PaCO2 was measured at 40 m depth, and it was found that baseline values of 37.7 mmHg had increased to 42 mmHg at depth (Bosco et al. 2018), but these were not maximal‐effort dives.

Competitive breath‐hold divers repeatedly expose themselves to hypercapnia and hypoxia, which increases tolerance to these stimuli due to a blunted ventilatory response to hypercapnia and/or hypoxia (Ferretti et al. 1991). During a breath‐hold, PaO2 will continue to drop as long as apnoea is extended, while PaCO2 concomitantly rises, causing hypoxia‐ and hypercapnia‐induced chemoreceptor activity in carotid and aortic bodies (Parkes, 2006). The resulting neural activity causes involuntary contractions of the diaphragm and inspiratory muscles, known as involuntary breathing movements (IBM; Hentsch & Ulmer, 1984). While untrained individuals may terminate apnoea shortly after the onset of IBM's, competitive freedivers can consciously suppress this respiratory sensory information due to training‐induced psychological tolerance until discomfort and/or signs of asphyxia (tunnel vision, hearing distortion) indicates them to break apnoea, before losing consciousness (Schagatay, 2009). Thus, in untrained individuals, the breaking point of apnoea will most likely be influenced by hypercapnia alone, while the combination of both hypoxia and, to a lesser extent, hypercapnia, will be the determining factor for competitive freedivers. Freedivers also possess a powerful "diving response" which efficiently reduces metabolism and oxygen consumption (Schagatay, 2009).

The responses to extreme hypoxia and hypercapnia are not only a feature of elite breath‐hold divers, as studies show that this adaptation can be trained (Hentsch & Ulmer, 1984; Engan et al. 2013). Breath‐holding therefore seems to be a good in vivo model to understand severe hypoxia, which may be useful to test hypotheses regarding the ventilatory drive on healthy individuals.

Additionally, when hypoxia occurs, an early response is the rapid splenic contraction which elevates haematocrit. This response has been observed during breath‐holding (Baković et al. 2003; Schagatay et al. 2005), at high altitude (Purdy et al. 2019; Schagatay et al. 2020) and under hypobaric hypoxia (Richardson et al. 2008; Lodin‐Sundström & Schagatay, 2010). It allows an increase in oxygen blood content by 10% without any changes in SpO2. So far, this response has not been studied in clinical situations related to hypoxia, but it was evident in drowning victims (Haffner et al. 1994) and could have importance in clinical conditions.

We would like to remark on an observation of the authors in regard to the lack of an excessive ventilatory response that could reduce self‐induced lung injury (Mascheroni et al. 1988; Brochard et al. 2017). We believe that a more holistic view that includes our natural defence mechanisms against hypoxia would be fruitful for better understanding of asymptomatic hypoxaemia. We advocate for this more holistic view as organism survival can be addressed in multiple ways.

Additional information

Competing interests

None declared.

Author contributions

All authors have approved the final version of the manuscript and agree to be accountable for all aspects of the work. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed.

Funding

None.

Supporting information

Peer Review History

Edited by: Ian Forsythe & Scott Powers

Linked articles: This Letter refers to an article by Simonson et al. To read the article, visit https://doi.org/10.1113/JP280769.

The peer review history is available in the Supporting Information section of this article (https://doi.org/10.1113/JP281882#support‐information‐section).

References

  1. Baković D, Valic Z, Eterović D, Vuković I, Obad A, Marinović‐Terzić I & Dujić Z (2003). Spleen volume and blood flow response to repeated breath‐hold apneas. J Appl Physiol 95, 1460–1466. [DOI] [PubMed] [Google Scholar]
  2. Bosco G, Rizzato A, Martani L, Schiavo S, Talamonti E, Garetto G, Paganini M, Camporesi EM & Moon RE (2018). Arterial Blood Gas Analysis in Breath‐Hold Divers at Depth. Front Physiol, 9. 10.3389/fphys.2018.01558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brochard L, Slutsky A & Pesenti A (2017). Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med 195, 438–442. [DOI] [PubMed] [Google Scholar]
  4. Engan H, Richardson MX, Lodin‐Sundström A, van Beekvelt M & Schagatay E (2013). Effects of two weeks of daily apnea training on diving response, spleen contraction, and erythropoiesis in novel subjects. Scand J Med Sci Sport 23, 340–348. [DOI] [PubMed] [Google Scholar]
  5. Ferretti G, Costa M, Ferrigno M, Grassi B, Marconi C, Lundgren CEG & Cerretelli P (1991). Alveolar gas composition and exchange during deep breath‐hold diving and dry breath holds in elite divers. J Appl Physiol 70, 794–802. [DOI] [PubMed] [Google Scholar]
  6. Haffner HT, Graw M & Erdelkamp J (1994). Spleen findings in drowning. Forensic Sci Int 66, 95–104. [DOI] [PubMed] [Google Scholar]
  7. Hentsch U & Ulmer H V (1984). Trainability of underwater breath‐holding time. Int J Sports Med 5, 343–347. [DOI] [PubMed] [Google Scholar]
  8. Huang L (2014). High altitude medicine in China in the 21st century: opportunities and challenges. Mil Med Res 1, 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Li X & Ma X (2020). Acute respiratory failure in COVID‐19: Is it “typical” ARDS? Crit Care 24, 1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lindholm P & Lundgren CEG (2006). Alveolar gas composition before and after maximal breath‐holds in competitive divers. Undersea Hyperb Med 33, 463–467. [PubMed] [Google Scholar]
  11. Liner MH & Linnarsson D (1994). Tissue oxygen and carbon dioxide stores and breath‐hold diving in humans. J Appl Physiol 77, 542–547. [DOI] [PubMed] [Google Scholar]
  12. Lodin‐Sundström A & Schagatay E (2010). Spleen contraction during 20 min normobaric hypoxia and 2 min apnea in humans. Aviat Sp Environ Med 81, 545–549. [DOI] [PubMed] [Google Scholar]
  13. Martin DS & Grocott MPW (2013). Oxygen therapy in critical illness: precise control of arterial oxygenation and permissive hypoxemia. Crit Care Med 41, 423–432. [DOI] [PubMed] [Google Scholar]
  14. Mascheroni D, Kolobow T, Fumagalli R, Moretti MP, Chen V & Buckhold D (1988). Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study. Intensive Care Med 15, 8–14. [DOI] [PubMed] [Google Scholar]
  15. Overgaard K, Friis S, Pedersen RB & Lykkeboe G (2006). Influence of lung volume, glossopharyngeal inhalation and P ETO2 and P ETCO2 on apnea performance in trained breath‐hold divers. Eur J Appl Physiol 97, 158–164. [DOI] [PubMed] [Google Scholar]
  16. Panwar R, Hardie M, Bellomo R, Barrot L, Eastwood GM, Young PJ, Capellier G, Harrigan PWJ & Bailey M (2016). Conservative versus liberal oxygenation targets for mechanically ventilated patients: a pilot multicenter randomized controlled trial. Am J Respir Crit Care Med 193, 43–51. [DOI] [PubMed] [Google Scholar]
  17. Parkes MJ (2006). Breath‐holding and its breakpoint. Exp Physiol 91, 1–15. [DOI] [PubMed] [Google Scholar]
  18. Pearn JH, Franklin RC & Peden AE (2015). Hypoxic blackout: Diagnosis, risks, and prevention. Int J Aquat Res Educ 9, 342–347. [Google Scholar]
  19. Purdy GM, James MA, Rees JL, Ondrus P, Keess JL, Day TA & Steinback CD (2019). Spleen reactivity during incremental ascent to altitude. J Appl Physiol 126, 152–159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rahn H & Otis AB (1949). Man's respiratory response during and after acclimatization to high altitude. Am J Physiol 157, 445–462. [DOI] [PubMed] [Google Scholar]
  21. Richardson MX, Lodin A, Reimers J & Schagatay E (2008). Short‐term effects of normobaric hypoxia on the human spleen. Eur J Appl Physiol 104, 395–399. [DOI] [PubMed] [Google Scholar]
  22. Schagatay E (2009). Predicting performance in competitive apnoea diving. Part I: Static apnoea. Diving Hyperb Med 39, 88–99. [PubMed] [Google Scholar]
  23. Schagatay E, Haughey H & Reimers J (2005). Speed of spleen volume changes evoked by serial apneas. Eur J Appl Physiol 93, 447–452. [DOI] [PubMed] [Google Scholar]
  24. Schagatay E, Lunde A, Nilsson S, Palm O & Lodin‐Sundström A (2020). Spleen contraction elevates hemoglobin concentration at high altitude during rest and exercise. Eur J Appl Physiol 120, 2693–2704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Simonson TS (2015). Altitude adaptation: a glimpse through various lenses. High Alt Med Biol 16, 125–137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Simonson TS, Baker TL, Banzett RB, Bishop T, Dempsey JA, Feldman JL, Guyenet PG, Hodson EJ, Mitchell GS, Moya EA, Nokes BT, Orr JE, Owens RL, Poulin M, Rawling JM, Schmickl CN, Watters JJ, Younes M & Malhotra A. (2021). Silent hypoxaemia in COVID‐19 patients. J Physiol 599, 1057–1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tobin MJ (1990). Dyspnea. Pathophysiologic basis, clinical presentation, and management. Arch Intern Med 150, 1604–1613. [DOI] [PubMed] [Google Scholar]
  28. Tobin MJ, Laghi F & Jubran A (2020). Why COVID‐19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 202, 356–360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. West JB (2006). Human responses to extreme altitudes. Integr Comp Biol 46, 25–34. [DOI] [PubMed] [Google Scholar]
  30. West JB (2019). Lessons from extreme altitudes. Front Physiol 10, 703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H & Cao B (2020). Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054–1062. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Peer Review History


Articles from The Journal of Physiology are provided here courtesy of Wiley

RESOURCES